AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responsesMarijn A. Gillissen(Amsterdam UMC Location University of Amsterdam), Mette D. Hazenberg(Amsterdam Neuroscience)BloodOctober 23, 201710.1182/blood-2017-02-768762Cited by 29SaveCiteExport RISWatch citationsRelated PapersHuman ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease|Blood Advances|2019|33